NICOTINE & TOBACCO RESEARCH, published by Oxford University Press, is a leading journal dedicated to advancing the understanding of nicotine and tobacco-related issues through rigorous research and analysis. Established in 1999, this esteemed journal has become a critical resource for scholars and practitioners in the fields of public health, environmental, and occupational health, maintaining a prestigious Q1 classification in its category as of 2023. With an impressive ranking of 67 out of 665 in the Scopus database, placing it in the 90th percentile, it is recognized for its high-quality contributions that resonate with current global health challenges. Although open access options are not available, the journal’s articles are accessible to a broad audience, ensuring that cutting-edge research reaches those who need it most. As it looks toward 2024 and beyond, NICOTINE & TOBACCO RESEARCH remains committed to promoting innovative research that informs policies and practices aimed at reducing tobacco use and its associated harms, thus playing a pivotal role in enhancing public health worldwide.

AIDS AND BEHAVIOR, published by SPRINGER/PLENUM PUBLISHERS, is a leading scholarly journal dedicated to the interdisciplinary study of HIV/AIDS, focusing particularly on the behavioral aspects of the epidemic. With an impressive impact factor reflected in its Q1 rankings across key categories including Infectious Diseases, Public Health, and Social Psychology, this journal serves as a vital resource for researchers, clinicians, and public health professionals. It encompasses a wide scope of research, from the psychosocial factors influencing HIV transmission to innovative interventions that promote safe practices. Although it does not offer open access, the journal's rigorous peer-review process ensures the dissemination of high-quality, impactful research. Covering data from 1997 to 2024, AIDS AND BEHAVIOR is positioned at the forefront of advancements in the field, making it an essential addition to any academic library and a must-read for those involved in combating HIV/AIDS.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

TOBACCO CONTROL is a leading journal published by the BMJ Publishing Group, dedicated to advancing the field of public health, especially concerning tobacco usage and its multifaceted impacts on society. With an ISSN of 0964-4563 and E-ISSN of 1468-3318, this journal offers unparalleled insights into tobacco control policy, epidemiology, and behavioral studies, fostering a platform for research that can significantly influence public health strategies worldwide. Recognized with a Q1 ranking in the fields of Health (social science) and Public Health, Environmental and Occupational Health for 2023, TOBACCO CONTROL holds a prestigious position among the top journals in its domain, with an impressive Scopus rank of #17 out of 371 in Health (social science) and #48 out of 665 in Public Health. Through its commitment to rigorous peer review and high-quality research articles, the journal aims to disseminate knowledge that can combat the tobacco epidemic, ultimately contributing to improved health outcomes. Although not open access, the journal's dedicated focus on illuminating effective tobacco control measures makes it an essential resource for researchers, policymakers, and health professionals alike.

Annals of the American Thoracic Society is a premier journal dedicated to advancing the field of pulmonary and respiratory medicine. Published by the American Thoracic Society, this journal offers an invaluable platform for researchers and clinicians to disseminate cutting-edge research, clinical insights, and innovative methodologies. With an impressive impact factor and ranked in the top Q1 category of its field (2023) and within the top 20 of 155 according to Scopus rankings, it is positioned as a leading force in shaping clinical practice and research directions. The journal's convergence years from 2013 to 2024 indicate a commitment to providing timely and relevant content at the forefront of pulmonary health. While not an open-access journal, it ensures broad accessibility to its significant contributions in respiratory medicine, making it an essential resource for professionals, researchers, and students alike endeavoring to deepen their understanding and improve outcomes in thoracic health.

JOURNAL OF DRUG EDUCATION, published by SAGE Publications Inc, serves as a vital platform for disseminating research and scholarly articles in the fields of health education, medicine, and mental health, focusing on drug-related issues. With its history dating back to 1972 and an ongoing publication cycle through 2024, the journal aims to enrich professional practice and inform policy-making through rigorous research. Although it does not currently operate under an Open Access model, the journal holds respectable rankings, finding itself in the third quartile across multiple categories including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, as per the 2023 metrics. This evaluation signifies its contribution to the discourse surrounding drug education and public health albeit within a competitive landscape. Scholars, researchers, and practitioners in the field are encouraged to engage with and contribute to this important dialogue addressing drug-related challenges in contemporary society.

Korean Journal of Family Medicine is a prestigious open access journal published by the Korean Academy of Family Medicine since 1991, dedicated to advancing the field of family medicine in South Korea and beyond. With a robust ISSN of 2092-6715, the journal holds an impressive ranking in the Q2 quartile of Family Practice as of 2023, reflecting its significant impact within the medical community. Ranked 11th out of 56 in the family practice category on Scopus, it proudly represents the top 81st percentile of its field, making it a crucial resource for researchers, practitioners, and students alike. The journal's aim is to disseminate cutting-edge research and robust clinical findings that enhance the practice of family medicine, thereby promoting improved health outcomes for diverse populations. Contributors can access the journal freely, ensuring that high-quality research is available to all, fostering collaboration and innovation in family medicine.

Allergy Asthma & Respiratory Disease is a pioneering journal dedicated to advancing research and clinical practice in the fields of allergy, asthma, and related respiratory diseases. Published by the esteemed Korean Academy of Asthma Allergy & Clinical Immunology, this journal aims to disseminate high-quality, peer-reviewed articles that contribute to the understanding, diagnosis, and treatment of these prevalent health issues. Although it operates under a subscription model, it maintains a robust reputation for being a pivotal resource in respiratory health, attracting authors and researchers worldwide. The journal emphasizes interdisciplinary approaches and encourages submissions that span from molecular biology to public health perspectives, making it a vital platform for professionals, researchers, and students eager to deepen their knowledge in respiratory medicine. With a commitment to fostering academic discourse in South Korea and beyond, Allergy Asthma & Respiratory Disease is positioned as a significant contributor to the global conversation on respiratory health.

Infectious Diseases of Poverty, published by BMC, is a leading open-access journal dedicated to addressing the critical intersection of infectious diseases and poverty. Since its inception in 2012, this influential journal has contributed significantly to the fields of public health, infectious diseases, and environmental health. With impressive rankings placing it in the top quartile (Q1) across multiple categories—including Infectious Diseases and Public Health, Environmental and Occupational Health—it stands as a vital resource for researchers and practitioners alike. The journal's commitment to accessibility ensures that high-quality research is available to a global audience, fostering collaboration and knowledge sharing. Based in the UK, Infectious Diseases of Poverty aims to publish innovative research that sheds light on the complexities of infectious diseases and their socio-economic determinants, ultimately working to improve health outcomes in vulnerable populations around the world. With its robust impact factor and esteemed standing within the academic community, this journal serves as an essential platform for advancing the understanding and management of infectious diseases related to poverty.

Journal of Inflammation-London, published by BMC, is a premier open access journal dedicated to advancing the understanding of inflammation, a critical process underlying numerous diseases including autoimmune disorders, cancer, and cardiovascular conditions. With its inception in 2004, the journal has consistently delivered high-quality research that bridges basic science and clinical applications, maintaining a significant place in the academic community. It holds impressive rankings within the Q2 category for both Cell Biology and Clinical Biochemistry, reflecting its impactful contributions to these fields, where it ranks in the 73rd and 64th percentiles respectively. The journal is committed to open access principles, ensuring that all published articles are freely available to researchers, practitioners, and the global community, thereby fostering collaboration and innovation. Located in the United Kingdom, the journal continues to attract submissions from prominent researchers and institutions worldwide, solidifying its status as an essential resource for the latest developments in inflammation research.